Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

3 results
Display

Supporting Patients With Schizophrenia in the Era of COVID-19

Kim SW

The coronavirus disease 2019 (COVID-19) pandemic has drastically impacted our society and health care system. People with schizophrenia are more vulnerable to this burden of illness and related societal changes....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association of the First Antipsychotic Treatment Duration With the Re-Initiation of Treatment in Schizophrenia: A National Health Insurance Data-Based Study

Song M, Lee J, Kim H, Ahn S, Choi YJ, Jo YT, Joo SW

Objectives: The optimal duration of maintenance treatment for patients with first-episode schizophrenia (FES) remains unclear. We examined the first antipsychotic treatment duration and its association with re-initiation of treatment using...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Delayed Clozapine Initiation on Acute Treatment Response in Treatment-Resistant Schizophrenia

Yang SY, Choi JK, Park S, Park J

Objectives: Recent studies have reported that delayed initiation of clozapine can affect clinical response in patients with treatment-resistant schizophrenia (TRS). This study aimed to explore the relationship between delayed initiation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr